Literature DB >> 10667597

ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells.

K Kuramoto1, T Uesaka, A Kimura, M Kobayashi, H Watanabe, O Katoh.   

Abstract

Vascular endothelial growth factor (VEGF) inhibits radiation-induced apoptosis in the leukemia cell line, CMK86 (O. Katoh et al., Cancer Res., 55: 5687-5692, 1995). To elucidate the molecular mechanisms underlying this inhibitory effect of VEGF, we attempted to identify a transcription factor involved in the cellular response to VEGF stimulation. We cloned the cDNA of a novel Kruppel-type zinc finger (ZNF) gene, ZK7, from a cDNA library constructed from the human leukemia cell line CMK86 after incubation with VEGF. This cDNA encoded a protein of 289 amino acids, which contained a Kruppel-associated box A-box domain at the NH2 terminus and seven ZNF motifs at the COOH terminus. These ZNF motifs were identical to those of HZF16 (M. Saleh et al., Am. J. Hum. Genet., 52: 192-203, 1993). ZK7 and HZF16 genes appear to be the splice variants transcribed from the same gene. Northern blotting and quantitative reverse transcription-PCR analysis revealed that expression of ZK7 mRNA in CMK86 cells and human hematopoietic progenitor cells was increased after VEGF stimulation, whereas that of HZF16 mRNA remained unchanged. To examine the function of ZK7 protein, we generated clones of a human monocytoid leukemia cell line, U937, which were stably transfected with ZK7 or HZF16 cDNA. Importantly, ZK7-overexpressing cells had lower sensitivity to ionizing radiation and the chemotherapeutic agent etoposide than U937 parent cells or HZF16-overexpressing cells. Therefore, ZK7 protein may be involved in the inhibitory effect of VEGF on apoptotic cell death in human hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10667597

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma.

Authors:  Hamidreza Maroof; Farhadul Islam; Armin Ariana; Vinod Gopalan; Alfred K Lam
Journal:  Endocrine       Date:  2017-08-24       Impact factor: 3.633

2.  De novo microduplication of the FMR1 gene in a patient with developmental delay, epilepsy and hyperactivity.

Authors:  Jaime Vengoechea; Aditi S Parikh; Shulin Zhang; Flora Tassone
Journal:  Eur J Hum Genet       Date:  2012-05-02       Impact factor: 4.246

3.  Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-kB pathway.

Authors:  Tao Wang; Xian-guo Wang; Jun-hua Xu; Xiang-Peng Wu; Hong-ling Qiu; Hong Yi; Wen-Xin Li
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

4.  ZNF367 inhibits cancer progression and is targeted by miR-195.

Authors:  Meenu Jain; Lisa Zhang; Myriem Boufraqech; Yi Liu-Chittenden; Kimberly Bussey; Michael J Demeure; Xiaolin Wu; Ling Su; Karel Pacak; Constantine A Stratakis; Electron Kebebew
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

5.  The Tumor Suppressor Role of Zinc Finger Protein 671 (ZNF671) in Multiple Tumors Based on Cancer Single-Cell Sequencing.

Authors:  Jian Zhang; Jianli Luo; Huali Jiang; Tao Xie; Jieling Zheng; Yunhong Tian; Rong Li; Baiyao Wang; Jie Lin; Anan Xu; Xiaoting Huang; Yawei Yuan
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

6.  Genomic and Transcriptomic Analyses Reveals ZNF124 as a Critical Regulator in Highly Aggressive Medulloblastomas.

Authors:  Zaili Luo; Xinran Dong; Jianzhong Yu; Yong Xia; Kalen P Berry; Rohit Rao; Lingli Xu; Ping Xue; Tong Chen; Yifeng Lin; Jiyang Yu; Guoying Huang; Hao Li; Wenhao Zhou; Q Richard Lu
Journal:  Front Cell Dev Biol       Date:  2021-02-18

7.  Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma.

Authors:  Gholamreza Bidkhori; Zahra Narimani; Saman Hosseini Ashtiani; Ali Moeini; Abbas Nowzari-Dalini; Ali Masoudi-Nejad
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.